FXR regulates liver repair after CCl4-induced toxic injury

Molecular Endocrinology

Volumn 24, Issue 5, 2010, Pages 886-897

  Meng, Zhipeng ^a   Wang, Yandong ^a   Wang, Lin ^a   Jin, Wen ^a   Liu, Nian ^a,b   Pan, Hao ^a   Liu, Lucy ^a   Wagman, Lawrence ^a   Forman, Barry M ^a   Huang, Wendong ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CARBON TETRACHLORIDE; DNA; FARNESOID X RECEPTOR; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; GENE INDUCTION; LIVER INJURY; LIVER REGENERATION; LIVER TOXICITY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CARBON TETRACHLORIDE; CELLS, CULTURED; DRUG-INDUCED LIVER INJURY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; LIVER; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 77954837070     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0286     Document Type: Article

References (45)

1. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C 1995 Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687-693
2. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B 1999 Identification of a nuclear receptor for bile acids. Science 284:1362-1365
3. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM 1999 Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365-1368
4. Wang H, Chen J, Hollister K, Sowers LC, Forman BM 1999 Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3:543-553
5. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA 2000 A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526
6. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ 2000 Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507-515
7. Wang YD, Chen WD, Huang W 2008 FXR, a target for different diseases. Histol Histopathol 23:621-627
8. Russell DW 2003 The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72:137-174 (Pubitemid 36930444)
9. Van Mil SW, Milona A, Dixon PH, Mullenbach R, Geenes VL, Chambers J, Shevchuk V, Moore GE, Lammert F, Glantz AG, Mattsson LA, Whittaker J, Parker MG, White R, Williamson C 2007 Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 133:507-516
10. Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely AS, Strautnieks SS, Thompson RJ, Magid MS, Gordon R, Balasubramanian N, Suchy FJ, Shneider BL 2004 Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 126: 756-764
11. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Németh A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, Thompson RJ 1998 A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 20:233-238
12. van Mil SW, van der Woerd WL, van der Brugge G, Sturm E, Jansen PL, Bull LN, van den Berg IE, Berger R, Houwen RH, Klomp LW 2004 Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 127: 379-384
13. Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pellicciari R, Morelli A 2004 The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 127:1497-1512
14. Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, MacKenzie KI, Mansfield TA, Kliewer SA, Goodwin B, Jones SA 2003 Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 112: 1678-1687
15. Park YJ, Qatanani M, Chua SS, LaRey JL, Johnson SA, Watanabe M, Moore DD, Lee YK 2008 Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis. Hepatology 47:1578-1586
16. Cui YJ, Aleksunes LM, Tanaka Y, Goedken MJ, Klaassen CD 2009 Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. Toxicol Sci 110:47-60
17. Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD 2006 Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312: 233-236
18. Trudell JR, Bösterling B, Trevor AJ 1982 Reductive metabolism of carbon tetrachloride by human cytochromes P-450 reconstituted in phospholipid vesicles: mass spectral identification of trichloromethyl radical bound to dioleoyl phosphatidylcholine. Proc Natl Acad Sci USA 79:2678-2682
19. Yu C, Wang F, Jin C, Wu X, Chan WK, McKeehan WL 2002 Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. Am J Pathol 161:2003-2010
20. Noé J, Stieger B, Meier PJ 2002 Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 123:1659-1666 (Pubitemid 35231665)
21. Wang YD, Chen WD, Moore DD, Huang W 2008 FXR: a metabolic regulator and cell protector. Cell Res 18:1087-1095
22. Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W 2008 Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response. Hepatology 48:1632-1643
23. Fausto N, Campbell JS, Riehle KJ 2006 Liver regeneration. Hepatology 43:S45-S53
24. Ladu S, Calvisi DF, Conner EA, Farina M, Factor VM, Thorgeirsson SS 2008 E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/ mTOR and COX-2 in a mouse model of human liver cancer. Gastroenterology 135:1322-1332
25. Geier A, Kim SK, Gerloff T, Dietrich CG, Lammert F, Karpen SJ, Stieger B, Meier PJ, Matern S, Gartung C 2002 Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. J Hepatol 37:198-205
26. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE 1999 Stat3 as an oncogene. Cell 98:295-303
27. Riehle KJ, Campbell JS, McMahan RS, Johnson MM, Beyer RP, Bammler TK, Fausto N 2008 Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J Exp Med 205:91-103
28. Wang YD, Yang F, Chen WD, Huang X, Lai L, Forman BM, Huang W 2008 Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo. Mol Endocrinol 22:1622-1632
29. Huang YH, Chuang JH, Yang YL, Huang CC, Wu CL, Chen CL 2009 Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling. Lab Invest 89:1128-1139
30. Graf D, Kohlmann C, Haselow K, Gehrmann T, Bode JG, Häussinger D 2006 Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver. Hepatology 44:1206-1217
31. Yu H, Jove R 2004 The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 4:97-105 (Pubitemid 38198738)
32. Liu F, Song Y, Liu D 1999 Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6:1258-1266
33. Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C 2003 Repression of farnesoid X receptor during the acute phase response. J Biol Chem 278:8988-8995
34. Xu G, Pan LX, Li H, Forman BM, Erickson SK, Shefer S, Bollineni J, Batta AK, Christie J, Wang TH, Michel J, Yang S, Tsai R, Lai L, Shimada K, Tint GS, Salen G 2002 Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. J Biol Chem 277:50491-50496
35. Zhang Q, He F, Kuruba R, Gao X, Wilson A, Li J, Billiar TR, Pitt BR, Xie W, Li S 2008 FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells. Cardiovasc Res 77:560-569
36. Greve JW, Gouma DJ, Buurman WA 1989 Bile acids inhibit endotoxin- induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology 10:454-458
37. Liu H, Lo CR, Jones BE, Pradhan Z, Srinivasan A, Valentino KL, Stockert RJ, Czaja MJ 2000 Inhibition of c-Myc expression sensitizes hepatocytes to tumor necrosis factor-induced apoptosis and necrosis. J Biol Chem 275:40155-40162
38. Dai G, He L, Bu P, Wan YJ 2008 Pregnane X receptor is essential for normal progression of liver regeneration. Hepatology 47:1277-1287 (Pubitemid 351547914)
39. Yokoyama Y, Nagino M, Nimura Y 2007 Mechanism of impaired hepatic regeneration in cholestatic liver. J Hepatobiliary Pancreat Surg 14:159-166
40. Gao B 2005 Cytokines, STATs and liver disease. Cell Mol Immunol 2:92-100
41. Nakamura K, Nonaka H, Saito H, Tanaka M, Miyajima A 2004 Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 39:635-644
42. Omori N, Evarts RP, Omori M, Hu Z, Marsden ER, Thorgeirsson SS 1996 Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab Invest 75: 15-24 (Pubitemid 26250269)
43. Zhang L, Huang X, Meng Z, Dong B, Shiah S, Moore DD, Huang W 2009 Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration. Mol Endocrinol 23: 137-145
44. Chen WD, Wang YD, Zhang L, Shiah S, Wang M, Yang F, Yu D, Forman BM, Huang W 22 October, 2009 Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology 10.1002/hep23390
45. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H 2002 Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000-2008